Header Logo

Shiyoung Roh

Concepts (71)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Telemedicine
6
2024
307
0.890
 Why?
Glaucoma, Open-Angle
6
2023
37
0.850
 Why?
Glaucoma
4
2023
46
0.760
 Why?
Intraocular Pressure
7
2023
59
0.610
 Why?
Diabetic Retinopathy
3
2024
44
0.610
 Why?
Macular Degeneration
2
2024
178
0.340
 Why?
Product Packaging
1
2008
4
0.300
 Why?
Hyphema
1
2008
3
0.300
 Why?
Eye Injuries
1
2008
13
0.300
 Why?
Diabetes Mellitus
2
2023
515
0.280
 Why?
Wounds, Nonpenetrating
1
2008
103
0.280
 Why?
Patient Portals
1
2024
47
0.220
 Why?
Visual Acuity
3
2024
117
0.220
 Why?
Geographic Atrophy
1
2024
20
0.220
 Why?
Wet Macular Degeneration
1
2023
26
0.210
 Why?
Ophthalmology
1
2022
23
0.190
 Why?
Smartphone
1
2021
64
0.170
 Why?
Dark Adaptation
1
2019
8
0.160
 Why?
Follow-Up Studies
4
2024
2337
0.120
 Why?
Humans
15
2024
59356
0.110
 Why?
Pandemics
3
2023
615
0.110
 Why?
Intravitreal Injections
2
2024
49
0.100
 Why?
Optic Nerve
2
2023
25
0.100
 Why?
Patient Compliance
2
2024
349
0.090
 Why?
Anterior Chamber
1
2008
5
0.080
 Why?
Antihypertensive Agents
2
2007
162
0.070
 Why?
Phacoemulsification
1
2007
7
0.070
 Why?
Trabeculectomy
1
2007
8
0.070
 Why?
Cataract
1
2007
52
0.070
 Why?
Prostaglandins F, Synthetic
1
2006
1
0.070
 Why?
Amides
1
2006
52
0.060
 Why?
Cross-Sectional Studies
2
2021
2373
0.060
 Why?
Lipids
1
2006
300
0.050
 Why?
Telephone
1
2023
115
0.050
 Why?
Appointments and Schedules
1
2023
55
0.050
 Why?
Ranibizumab
1
2021
20
0.050
 Why?
Female
5
2024
30704
0.050
 Why?
Receptors, Vascular Endothelial Growth Factor
1
2021
33
0.050
 Why?
Nerve Fibers
1
2021
29
0.050
 Why?
Retinal Ganglion Cells
1
2021
27
0.050
 Why?
Bevacizumab
1
2021
57
0.050
 Why?
Diagnostic Techniques, Ophthalmological
1
2021
14
0.040
 Why?
Aged
4
2024
13416
0.040
 Why?
Photography
1
2021
40
0.040
 Why?
Angiogenesis Inhibitors
1
2021
76
0.040
 Why?
Retina
1
2021
115
0.040
 Why?
Recombinant Fusion Proteins
1
2021
490
0.040
 Why?
Retrospective Studies
2
2021
6071
0.040
 Why?
Visual Fields
1
2019
43
0.040
 Why?
Disease Progression
1
2023
1122
0.040
 Why?
Tomography, Optical Coherence
1
2021
209
0.040
 Why?
Referral and Consultation
1
2021
398
0.040
 Why?
Patient Satisfaction
1
2021
412
0.040
 Why?
Middle Aged
3
2024
16317
0.040
 Why?
Adolescent
1
2008
5824
0.040
 Why?
Prospective Studies
2
2019
3067
0.030
 Why?
Male
4
2024
27738
0.030
 Why?
Pilot Projects
1
2019
914
0.030
 Why?
Reproducibility of Results
1
2019
1561
0.030
 Why?
Aged, 80 and over
2
2019
5128
0.030
 Why?
Risk Factors
1
2022
4984
0.020
 Why?
Surveys and Questionnaires
1
2019
2513
0.020
 Why?
Tonometry, Ocular
1
2007
15
0.020
 Why?
Lens Implantation, Intraocular
1
2007
7
0.020
 Why?
Mitomycin
1
2007
24
0.020
 Why?
Bimatoprost
1
2006
1
0.020
 Why?
Cloprostenol
1
2006
1
0.020
 Why?
Ophthalmic Solutions
1
2006
7
0.020
 Why?
Double-Blind Method
1
2006
715
0.010
 Why?
Circadian Rhythm
1
2006
373
0.010
 Why?
Adult
1
2019
15669
0.010
 Why?
Roh's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (71)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_